News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
485,893 Results
Type
Article (8082)
Company Profile (140)
Press Release (477670)
Multimedia
Podcasts (5)
Webinars (6)
Section
Business (166777)
Career Advice (305)
Deals (25749)
Drug Delivery (7)
Drug Development (52957)
Employer Resources (14)
FDA (9765)
Job Trends (8583)
News (238259)
Policy (17915)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (492)
Accelerated approval (26)
ADA (18)
Adcomms (1)
Allergies (98)
Alliances (33162)
ALS (107)
Alzheimer's disease (985)
Antibody-drug conjugate (ADC) (280)
Approvals (10406)
Artificial intelligence (328)
ASCO (159)
Autoimmune disease (218)
Automation (29)
Bankruptcy (264)
Belgium (1)
Best Places to Work (6965)
BIO (36)
Biologics (9)
BIOSECURE Act (1)
Biosimilars (114)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (139)
Brain cancer (30)
Breast cancer (516)
Cancer (3739)
Cardiovascular disease (226)
Career advice (245)
Career pathing (1)
CAR-T (177)
CDMO (13)
Celiac Disease (1)
Cell therapy (484)
Cervical cancer (35)
Clinical research (48056)
Collaboration (1272)
Commercialization (3)
Compensation (1524)
Complete response letters (34)
COVID-19 (771)
CRISPR (64)
C-suite (797)
Cystic fibrosis (87)
Data (5828)
Denatured (4)
Depression (105)
Dermatology (67)
Diabetes (352)
Diagnostics (4206)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (158)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (166)
Earnings (73748)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88072)
Executive appointments (710)
FDA (12471)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (24)
Funding (938)
Gene editing (126)
Generative AI (9)
Gene therapy (329)
GLP-1 (299)
Government (951)
Grass and pollen (2)
Guidances (281)
Healthcare (9370)
Hematology (94)
HIV (53)
Huntington's disease (22)
IgA nephropathy (68)
Immunology and inflammation (101)
Immuno-oncology (61)
Indications (159)
Infectious disease (962)
Inflammatory bowel disease (128)
Inflation Reduction Act (4)
Influenza (85)
Intellectual property (259)
Interviews (41)
IPO (12389)
IRA (2)
Job creations (1970)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (60)
Legal (5196)
Licensing (17)
Liver cancer (45)
Longevity (19)
Lung cancer (533)
Lymphoma (257)
Machine learning (27)
Management (3)
Manufacturing (558)
Marketing (8)
MASH (118)
Medical affairs (2)
Medical device (8681)
Medtech (8836)
Mergers & acquisitions (14414)
Metabolic disorders (725)
mRNA (60)
Multiple sclerosis (107)
NASH (4)
Neurodegenerative disease (224)
Neuropsychiatric disorders (40)
Neuroscience (1859)
NextGen: Class of 2026 (3155)
Non-profit (843)
Obesity (233)
Opinion (10)
Ovarian cancer (161)
Pain (177)
Pancreatic cancer (206)
Parkinson's disease (204)
Partnered (12)
Patents (492)
Patient recruitment (526)
Patient selection (1)
Peanut (32)
People (41342)
Peptides (1)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15526)
Phase 2 (21471)
Phase 3 (14496)
Pipeline (7637)
Policy (18)
Postmarket research (1571)
Preclinical (6554)
Press Release (34)
Prostate cancer (193)
Psychedelics (7)
Radiopharmaceuticals (194)
Rare diseases (587)
Real estate (3024)
Recruiting (6)
Regenerative medicine (1)
Regulatory (14934)
Reports (23)
Research institute (587)
Resumes & cover letters (45)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (102)
Series A (158)
Series B (123)
Service/supplier (5)
Sickle cell disease (63)
Special edition (1)
Spinal muscular atrophy (91)
Sponsored (5)
Startups (2022)
Stomach cancer (3)
Supply chain (51)
The Weekly (1)
Vaccines (333)
Venture capital (17)
Weight loss (77)
Women's health (85)
Date
Today (67)
Last 7 days (439)
Last 30 days (1358)
Last 365 days (19090)
2026 (13438)
2025 (19254)
2024 (22989)
2023 (26545)
2022 (34599)
2021 (37177)
2020 (33472)
2019 (23277)
2018 (17517)
2017 (18776)
2016 (17924)
2015 (24271)
2014 (21683)
2013 (18135)
2012 (20227)
2011 (20442)
2010 (20333)
Location
Africa (229)
Alabama (77)
Alaska (2)
Arizona (309)
Arkansas (11)
Asia (17958)
Australia (2107)
California (12298)
Canada (3221)
China (542)
Colorado (493)
Connecticut (425)
Delaware (211)
Europe (24717)
Florida (1845)
Georgia (392)
Hawaii (3)
Idaho (46)
Illinois (724)
India (52)
Indiana (321)
Iowa (16)
Japan (418)
Kansas (102)
Kentucky (31)
Louisiana (27)
Maine (26)
Maryland (1227)
Massachusetts (8070)
Michigan (312)
Minnesota (569)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (120)
New Hampshire (60)
New Jersey (2682)
New Mexico (12)
New York (2883)
North Carolina (1312)
North Dakota (4)
Northern California (6180)
Ohio (291)
Oklahoma (14)
Oregon (18)
Pennsylvania (2290)
Puerto Rico (21)
Rhode Island (30)
South America (406)
South Carolina (77)
South Dakota (1)
Southern California (5118)
Tennessee (123)
Texas (1992)
United States (39863)
Utah (367)
Vermont (1)
Virginia (159)
Washington D.C. (38)
Washington State (955)
West Virginia (1)
Wisconsin (74)
Wyoming (1)
485,893 Results for "veru inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Metabolon Verus™ Metabolomics Profiling Kit Now Available to Order
September 8, 2026
·
7 min read
Press Releases
Veru to Participate in Fireside Chat at the 2026 Cantor Global Healthcare Conference
September 2, 2026
·
10 min read
Press Releases
Veru to Report Fiscal 2026 Third Quarter Financial Results on August 10th
August 3, 2026
·
10 min read
Press Releases
Veru to Participate in Fireside Chat at the Canaccord Genuity’s 46th Annual Growth Investors Conference
July 30, 2026
·
10 min read
Press Releases
Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress
August 10, 2026
·
19 min read
Press Releases
Veru to Present at 2026 Obesity & Weight Loss Drug Development Summit and Pre-Conference Workshop Day
July 7, 2026
·
10 min read
Press Releases
Veru Announces Full Enrollment for Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss
July 27, 2026
·
11 min read
Press Releases
Veru Announces Notice of Allowance for Key Methods of Use U.S. Patent for Enobosarm in Combination with Semaglutide for Quality Weight Loss
August 4, 2026
·
13 min read
Press Releases
Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines’ RASONQUE™) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial
September 8, 2026
·
24 min read
Press Releases
Veru to Report Fiscal 2026 Second Quarter Financial Results on May 13th
May 6, 2026
·
10 min read
1 of 48,590
Next
